FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887450462> ?p ?o ?g. }

• W2887450462 abstract "Introduction: In patients with advanced-stage ovarian cancer, FDA has recently granted approval of treatment with PARP inhibitors (PARPi) in patients harboring deleterious BRCA mutations (~25% of population). However, there is clear evidence of “BRCA-like” patients who respond to PARPi without BRCA mutations. To identify such patients, it has been shown that deficiency in homologous recombination repair leads to a common phenotype of genome-wide loss of heterozygosity (LOH). Depending on the cutoff employed, genomic LOH could identify more than twice the number of ovarian cancer patients who could benefit from PARPi than measuring BRCA alone. We present here an NGS-based platform developed and performed in compliance with FDA 21 CFR part 820. The assay provides a tumor measurement of BRCA1/2 (FDA-approved as FoundationFocus CDx BRCA) as well as genomic LOH, and is on the same platform as the comprehensive FoundationOne CDx, which interrogates 324 genes. Methods: DNA extracted from FFPE tumor tissue underwent whole-genome shotgun library construction and hybridization-based capture, followed by sequencing using Illumina HiSeq 4000. Sequence data were processed using a proprietary analysis pipeline designed to detect base substitutions, indels, copy number alterations (CNA), genomic rearrangements, microsatellite instability (MSI), and tumor mutational burden (TMB). A genome-wide LOH profile based on SNPs is measured as part of the CNA pipeline, and is summarized as the percentage of the tumor genome displaying LOH (scored from 0-100%), with ≥16% being considered LOH high based on clinical data derived from ARIEL2 Part 1, a phase II study of the PARPi rucaparib for the treatment of platinum-sensitive ovarian cancer (ARIEL2; NCT01891344) Results: For analytical validity, BRCA limit of detection (LoD) was at allele frequency 5.9% for substitutions and non-repetitive indels, and 30% tumor content for LOH. Overall percent agreement with comparator NGS assay was 97.3% for BRCA. No orthogonal platform concordance was established for LOH as no validated test exists. Within-assay reproducibility was measured with overall concordance of 100% for BRCA, and 98% for LOH. Conclusion: We developed a novel diagnostic assay (in compliance with FDA 21 CFR part 820) that can measure BRCA and genomic LOH simultaneously, and established robust analytical validation data. Citation Format: James X. Sun, Kevin Lin, Yali Li, Kyle Gowen, Yuting He, Coren Milbury, Christine Burns, Jun Luo, Steve Roels, Murtaza Mehdi, John Truesdell, Pei Ma, Lakshman Ramamurthy, Christine Vietz, Jeri Beltman, Thomas Harding, Doron Lipson, Jeffrey Ross, Vincent Miller, Philip Stephens, Michael Doherty, Julia Elvin. A validated diagnostic assay for identifying ovarian cancer patients with deleterious BRCA mutations and high genomic loss of heterozygosity (LOH) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 4544." @default.
• W2887450462 created "2018-08-22" @default.
• W2887450462 creator A5000194661 @default.
• W2887450462 creator A5000341594 @default.
• W2887450462 creator A5007398841 @default.
• W2887450462 creator A5007572366 @default.
• W2887450462 creator A5011609796 @default.
• W2887450462 creator A5011631723 @default.
• W2887450462 creator A5018324791 @default.
• W2887450462 creator A5023204946 @default.
• W2887450462 creator A5025096782 @default.
• W2887450462 creator A5029183165 @default.
• W2887450462 creator A5040121512 @default.
• W2887450462 creator A5041178213 @default.
• W2887450462 creator A5052319017 @default.
• W2887450462 creator A5054915817 @default.
• W2887450462 creator A5061190602 @default.
• W2887450462 creator A5062006821 @default.
• W2887450462 creator A5063383682 @default.
• W2887450462 creator A5069918197 @default.
• W2887450462 creator A5072909940 @default.
• W2887450462 creator A5077552075 @default.
• W2887450462 creator A5087003740 @default.
• W2887450462 creator A5088559019 @default.
• W2887450462 date "2018-07-01" @default.
• W2887450462 modified "2023-09-27" @default.
• W2887450462 title "Abstract 4544: A validated diagnostic assay for identifying ovarian cancer patients with deleterious BRCA mutations and high genomic loss of heterozygosity (LOH)" @default.
• W2887450462 doi "https://doi.org/10.1158/1538-7445.am2018-4544" @default.
• W2887450462 hasPublicationYear "2018" @default.
• W2887450462 type Work @default.
• W2887450462 sameAs 2887450462 @default.
• W2887450462 citedByCount "0" @default.
• W2887450462 crossrefType "proceedings-article" @default.
• W2887450462 hasAuthorship W2887450462A5000194661 @default.
• W2887450462 hasAuthorship W2887450462A5000341594 @default.
• W2887450462 hasAuthorship W2887450462A5007398841 @default.
• W2887450462 hasAuthorship W2887450462A5007572366 @default.
• W2887450462 hasAuthorship W2887450462A5011609796 @default.
• W2887450462 hasAuthorship W2887450462A5011631723 @default.
• W2887450462 hasAuthorship W2887450462A5018324791 @default.
• W2887450462 hasAuthorship W2887450462A5023204946 @default.
• W2887450462 hasAuthorship W2887450462A5025096782 @default.
• W2887450462 hasAuthorship W2887450462A5029183165 @default.
• W2887450462 hasAuthorship W2887450462A5040121512 @default.
• W2887450462 hasAuthorship W2887450462A5041178213 @default.
• W2887450462 hasAuthorship W2887450462A5052319017 @default.
• W2887450462 hasAuthorship W2887450462A5054915817 @default.
• W2887450462 hasAuthorship W2887450462A5061190602 @default.
• W2887450462 hasAuthorship W2887450462A5062006821 @default.
• W2887450462 hasAuthorship W2887450462A5063383682 @default.
• W2887450462 hasAuthorship W2887450462A5069918197 @default.
• W2887450462 hasAuthorship W2887450462A5072909940 @default.
• W2887450462 hasAuthorship W2887450462A5077552075 @default.
• W2887450462 hasAuthorship W2887450462A5087003740 @default.
• W2887450462 hasAuthorship W2887450462A5088559019 @default.
• W2887450462 hasConcept C104317684 @default.
• W2887450462 hasConcept C119054055 @default.
• W2887450462 hasConcept C121608353 @default.
• W2887450462 hasConcept C124942203 @default.
• W2887450462 hasConcept C135763542 @default.
• W2887450462 hasConcept C141231307 @default.
• W2887450462 hasConcept C143425029 @default.
• W2887450462 hasConcept C143589142 @default.
• W2887450462 hasConcept C153209595 @default.
• W2887450462 hasConcept C178169997 @default.
• W2887450462 hasConcept C180754005 @default.
• W2887450462 hasConcept C2779767149 @default.
• W2887450462 hasConcept C2780427987 @default.
• W2887450462 hasConcept C502942594 @default.
• W2887450462 hasConcept C54355233 @default.
• W2887450462 hasConcept C552990157 @default.
• W2887450462 hasConcept C61320498 @default.
• W2887450462 hasConcept C71924100 @default.
• W2887450462 hasConcept C86803240 @default.
• W2887450462 hasConceptScore W2887450462C104317684 @default.
• W2887450462 hasConceptScore W2887450462C119054055 @default.
• W2887450462 hasConceptScore W2887450462C121608353 @default.
• W2887450462 hasConceptScore W2887450462C124942203 @default.
• W2887450462 hasConceptScore W2887450462C135763542 @default.
• W2887450462 hasConceptScore W2887450462C141231307 @default.
• W2887450462 hasConceptScore W2887450462C143425029 @default.
• W2887450462 hasConceptScore W2887450462C143589142 @default.
• W2887450462 hasConceptScore W2887450462C153209595 @default.
• W2887450462 hasConceptScore W2887450462C178169997 @default.
• W2887450462 hasConceptScore W2887450462C180754005 @default.
• W2887450462 hasConceptScore W2887450462C2779767149 @default.
• W2887450462 hasConceptScore W2887450462C2780427987 @default.
• W2887450462 hasConceptScore W2887450462C502942594 @default.
• W2887450462 hasConceptScore W2887450462C54355233 @default.
• W2887450462 hasConceptScore W2887450462C552990157 @default.
• W2887450462 hasConceptScore W2887450462C61320498 @default.
• W2887450462 hasConceptScore W2887450462C71924100 @default.
• W2887450462 hasConceptScore W2887450462C86803240 @default.
• W2887450462 hasLocation W28874504621 @default.
• W2887450462 hasOpenAccess W2887450462 @default.
• W2887450462 hasPrimaryLocation W28874504621 @default.
• W2887450462 hasRelatedWork W1998219763 @default.
• W2887450462 hasRelatedWork W2020282938 @default.
• W2887450462 hasRelatedWork W2078303433 @default.
• W2887450462 hasRelatedWork W2086150352 @default.

• next